Warning: The NCBI web site requires JavaScript to function. more...
Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ, Schiemann WP.
Breast Cancer Res. 2006;8(4):R42.
Related citations
Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Cancer Res. 2007 Apr 15;67(8):3752-8.
Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.
Galliher-Beckley AJ, Schiemann WP.
Carcinogenesis. 2008 Feb;29(2):244-51. Epub 2008 Jan 3.
The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP, Neil JR, Schiemann BJ, Schiemann WP.
Breast Cancer Res. 2005;7(5):R844-53. Epub 2005 Aug 23.
Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M, Shintani Y, Wheelock MJ, Johnson KR.
J Biol Chem. 2006 Jan 6;281(1):59-68. Epub 2005 Nov 1.
Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA, Amin JD, Kirschmann DA, Schiemann WP.
Neoplasia. 2011 May;13(5):406-18.
The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA, Parvani JG, Schiemann WP.
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. Epub 2010 May 15. Review.
Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP.
Carcinogenesis. 2008 Dec;29(12):2243-51. Epub 2008 Aug 19.
Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL.
J Biol Chem. 2001 Dec 14;276(50):46707-13. Epub 2001 Oct 5.
p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
Wendt MK, Smith JA, Schiemann WP.
J Biol Chem. 2009 Dec 4;284(49):34145-56. Epub 2009 Oct 12.
Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Oncogene. 2010 Dec 9;29(49):6485-98. Epub 2010 Aug 30.
Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1.
Kim JT, Joo CK.
J Biol Chem. 2002 Aug 30;277(35):31938-48. Epub 2002 Jun 13.
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
Cancer Res. 2004 Aug 1;64(15):5200-11.
Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H, Sebens S, Groth S, Gieseler F, Fändrich F.
Int J Oncol. 2011 Mar;38(3):797-805. doi: 10.3892/ijo.2011.897. Epub 2011 Jan 11.
Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
Wang SE, Wu FY, Shin I, Qu S, Arteaga CL.
Mol Cell Biol. 2005 Jun;25(11):4703-15.
Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.
Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, Moses HL.
Breast Cancer Res. 2004;6(3):R215-31. Epub 2004 Mar 17.
HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
Wilson CA, Cajulis EE, Green JL, Olsen TM, Chung YA, Damore MA, Dering J, Calzone FJ, Slamon DJ.
Breast Cancer Res. 2005;7(6):R1058-79. Epub 2005 Nov 8.
TGF-beta control of cell proliferation.
Huang SS, Huang JS.
J Cell Biochem. 2005 Oct 15;96(3):447-62. Review.
TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z.
Respir Res. 2005 Jun 9;6:56.
Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I.
J Cell Biochem. 2005 Aug 1;95(5):918-31.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on